✦ LIBER ✦

Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial

✍ Scribed by Ludwig Kappos; Mark S Freedman; Chris H Polman; Gilles Edan; Hans-Peter Hartung; David H Miller; Xavier Montalbán; Frederik Barkhof; Ernst-Wilhelm Radü; Carola Metzig; Lars Bauer; Vivian Lanius; Rupert Sandbrink; Christoph Pohl

Book ID: 114409312
Publisher: The Lancet
Year: 2009
Tongue: English
Weight: 239 KB
Volume: 8
Category: Article
ISSN: 1474-4465
DOI: 10.1016/s1474-4422(09)70237-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of early versus delayed interfero

Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study

✍ Ludwig Kappos; Mark S Freedman; Chris H Polman; Gilles Edan; Hans-Peter Hartung; 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 183 KB

Cost-Effectiveness Analysis of Interfero

Cost-Effectiveness Analysis of Interferon Beta-1b for the Treatment of Patients With a First Clinical Event Suggestive of Multiple Sclerosis

✍ John P. Caloyeras; Bin Zhang; Cheng Wang; Marianne Eriksson; Sten Fredrikson; Ka 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 882 KB

ND4 COST-UTILITY OF INTERFERON BETA-1B I

ND4 COST-UTILITY OF INTERFERON BETA-1B IN THE TREATMENT OF PATIENTS WITH A CLINICALLY ISOLATED SYNDROME SUGGESTIVE OF MULTIPLE SCLEROSIS: MODEL UTILIZING FIVE YEAR BENEFIT DATA

✍ JP Caloyeras; B Harrow; C Wang; K Beckmann; V Knappertz; C Pohl; JD Miller; MW R 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB